Healthcare Hedge Fund Just Invested $24.5M in Immunovant
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
This piece breaks down why Total Market Return 2024 matters, highlighting drivers, risks, and practical steps to align holdings with your goals.
28,491 articlesA healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
SpaceX has experienced a sharp move after going public, sparking questions about lockups and what it means for future...
The SPDR S&P Semiconductor ETF jumps roughly 12% amid resilient AI-related demand, yet Intel remains a weakness in an...
Synopsys sits at the core of AI driven chip design as investors weigh a path to $700 this year. A debt load from the ...
Microsoft stock moved higher in a day of broad market gains. This article breaks down the top drivers behind the surg...
What did spacex stock close on its inaugural trading day? This article breaks down a hypothetical first-day close, wh...
Discover two AI stocks that Wall Street analysts believe could move significantly higher. Learn what makes them stron...
Markets are unsettled, but long-term investors can find value. This guide highlights three AI leaders that are curren...
Begin your week with a curated set of investing insights. These 10 Monday reads turn market noise into concrete steps...
Private credit has grown rapidly, bringing yield and risk in equal measure. This article breaks down what JPMorgan Ch...
Geopolitical headlines push crypto traders toward nonstop venues. This piece explains why hyperliquid's token rises w...
A private habit can quietly drain a budget. This piece examines how the idea behind holland says drinking years trans...